Clinical Trial Update: [E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating EPANOVA in combination with a statin to reduce non-HDL cholesterol in patients with hypertriglyceridemia and cardiovascular disease; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertriglyceridemia

Drugs mentioned

• Epanova (icosapent ethyl)
• Statin (unspecified)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertriglyceridemia, Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-12-05